ALEMBIC OSELTAMIVIR oseltamivir (as phosphate) 45 mg hard capsule blister pack

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

oseltamivir phosphate, Quantity: 59.117 mg

Available from:

Alembic Pharmaceuticals Australia Pty Ltd

Pharmaceutical form:

Capsule, hard

Composition:

Excipient Ingredients: povidone; sodium stearylfumarate; purified talc; pregelatinised maize starch; croscarmellose sodium; titanium dioxide; purified water; Gelatin; iron oxide black; propylene glycol; indigo carmine; ethanol; butan-1-ol; isopropyl alcohol; Shellac; strong ammonia solution

Administration route:

Oral

Units in package:

10

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

Oseltamivir Phosphate is indicated for the treatment of infections due to influenza A and B viruses in adults and children including full-term neonates. Treatment should commence as soon as possible, but no later than 48 hours after the onset of the initial symptoms of infection.,Oseltamivir Phosphate is indicated for the prevention of influenza in adults and children aged 1 year and older. Vaccination is the preferred method of routine prophylaxis against infection with influenza virus.

Product summary:

Visual Identification: Opaque Grey cap/ opaque Grey body hard gelatin capsules size 4 having imprinting A 293 on cap with blue ink.; Container Type: Blister Pack; Container Material: PVC/PE/PVDC/Al; Container Life Time: 30 Months; Container Temperature: Store below 25 degrees Celsius

Authorization status:

Registered

Authorization date:

2022-11-17